Correlation Between Bank of Nova Scotia and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of Nova Scotia and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of Nova Scotia and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of Nova and Pfizer Inc CDR, you can compare the effects of market volatilities on Bank of Nova Scotia and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of Nova Scotia with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of Nova Scotia and Pfizer.

Diversification Opportunities for Bank of Nova Scotia and Pfizer

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bank and Pfizer is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Bank of Nova and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Bank of Nova Scotia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of Nova are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Bank of Nova Scotia i.e., Bank of Nova Scotia and Pfizer go up and down completely randomly.

Pair Corralation between Bank of Nova Scotia and Pfizer

Assuming the 90 days trading horizon Bank of Nova is expected to generate 0.56 times more return on investment than Pfizer. However, Bank of Nova is 1.79 times less risky than Pfizer. It trades about 0.24 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.06 per unit of risk. If you would invest  7,527  in Bank of Nova on September 12, 2024 and sell it today you would earn a total of  389.00  from holding Bank of Nova or generate 5.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bank of Nova  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Bank of Nova Scotia 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of Nova are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Bank of Nova Scotia displayed solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Bank of Nova Scotia and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of Nova Scotia and Pfizer

The main advantage of trading using opposite Bank of Nova Scotia and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of Nova Scotia position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Bank of Nova and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope